Förutom imatinib hade 35% av patienterna tidigare fått cytostatika, 65% hade tidigare fått interferon och 10% hade tidigare fått stamcellstransplantation. ###>In addition to imatinib, 35% of patients had received prior cytotoxic chemotherapy, 65% had received prior interferon, and 10% had received a prior stem cell transplant.